Patent classifications
C07C317/02
NOVEL PIPERIDINE DERIVATIVES
The invention relates to a compound of formula (I)
##STR00001##
wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
NOVEL PIPERIDINE DERIVATIVES
The invention relates to a compound of formula (I)
##STR00001##
wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
Electrolyte, lithium secondary battery including the electrolyte, and method of manufacturing the electrolyte
An electrolyte including: a lithium salt; a non-aqueous solvent; a compound represented by Formula 1; and a compound represented by Formula 2 ##STR00001##
wherein R.sub.1, R.sub.2, R.sub.3, R.sub.11, and R.sub.12 in Formulae 1 and 2 are as described in the detailed description.
Electrolyte, lithium secondary battery including the electrolyte, and method of manufacturing the electrolyte
An electrolyte including: a lithium salt; a non-aqueous solvent; a compound represented by Formula 1; and a compound represented by Formula 2 ##STR00001##
wherein R.sub.1, R.sub.2, R.sub.3, R.sub.11, and R.sub.12 in Formulae 1 and 2 are as described in the detailed description.
ELECTROLYTE, LITHIUM SECONDARY BATTERY INCLUDING THE ELECTROLYTE, AND METHOD OF MANUFACTURING THE ELECTROLYTE
An electrolyte including: a lithium salt; a non-aqueous solvent; a compound represented by Formula 1; and a compound represented by Formula 2
##STR00001##
wherein R.sub.1, R.sub.2, R.sub.3, R.sub.11, and R.sub.12 in Formulae 1 and 2 are as described in the detailed description.
ELECTROLYTE, LITHIUM SECONDARY BATTERY INCLUDING THE ELECTROLYTE, AND METHOD OF MANUFACTURING THE ELECTROLYTE
An electrolyte including: a lithium salt; a non-aqueous solvent; a compound represented by Formula 1; and a compound represented by Formula 2
##STR00001##
wherein R.sub.1, R.sub.2, R.sub.3, R.sub.11, and R.sub.12 in Formulae 1 and 2 are as described in the detailed description.
Protein tyrosine phosphatases or SHP2 inhibitors and uses thereof
Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.
NOVEL PIPERIDINE DERIVATIVES
The invention relates to a compound of formula (I)
##STR00001##
wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
NOVEL PIPERIDINE DERIVATIVES
The invention relates to a compound of formula (I)
##STR00001##
wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
Piperidine derivatives
The invention relates to a compound of formula (I) ##STR00001##
wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.